Results 131 to 140 of about 823,424 (276)
Abstract The first 1000 days of life represent a critical window for gut microbiome assembly, with lifelong implications for child growth, immune development, and disease risk. This review synthesizes evidence on maternal, perinatal, and especially nutritional factors that influence early‐life intestinal colonization and highlights the consequences of ...
Carly Burow +4 more
wiley +1 more source
Abstract Background Metabolic dysfunction‐associated steatohepatitis (MASH) is associated with altered intestinal permeability, allowing microbial products to translocate to the liver via the enterohepatic circulation and contributes to disease progression. The aim of our study was to evaluate the association between probiotic supplementation and serum
Bruna Concheski de Moura +10 more
wiley +1 more source
Abstract Fecal microbiota transplantation (FMT) is a safe and effective treatment for recurrent or refractory Clostridioides difficile infection (rCDI) in children and adults. This review outlines the evidence behind FMT for rCDI, considerations in special pediatric populations, and limitations in current practice due to FMT access for patients under ...
Nikhil Pai +3 more
wiley +1 more source
Abstract Objectives Clostridioides difficile infection (CDI) is a recognised complication of inflammatory bowel disease (IBD). In adults, CDI has been linked to increased long‐term colectomy risk, but data on its impact in paediatric IBD remain scarce. We aimed to assess the medium‐term course of IBD after CDI in children.
Charlotte Souche +13 more
wiley +1 more source
Abstract Food processing can improve safety, shelf life, digestibility and sensory quality, but it can also alter the food matrix, remove microbiota‐accessible substrates and introduce additives or heat‐derived compounds that modify host–microbe interactions.
Elijah Kolawole Oladipo +10 more
wiley +1 more source
This review systematically compares the size‐dependent toxicity of microplastics and nanoplastics in the intestine, liver, kidney, lung, and brain. Particle size determines bioavailability, barrier penetration, and injury mechanisms. Because of their small size and high surface reactivity, NPs readily cross the intestinal epithelium and blood–brain ...
Yixian Cheng +14 more
wiley +1 more source
Abstract Gastrointestinal dysfunction is increasingly recognized as a core feature of Parkinson's disease (PD), affecting quality of life, nutrition, medication response, and potentially the earliest stages of pathogenesis. This perspective traces the evolution of the gut from a neglected source of non‐motor symptoms to a central component of ...
Filip Scheperjans +4 more
wiley +1 more source
Editorial: Multi-Omics Study on Gut Microbiota Related to Faecal Microbiota Transplantation
Jingtong Wu +13 more
doaj +1 more source
Transplantation of intestinal microbiota: therapeutic potential at diseases of digestive organs
The aim of review. To analyze accumulated world data on human fecal microbiota transplantation (FMT) at treatment of digestive diseases.Summary. Review highlights basic problems of fecal microbiota transplantation — i.e.
E. V. Shrayner +3 more
doaj
Faecal microbiota transplantation: an emerging solution for recurrent infections
Clostridioides difficile infection was one of the main causes of antibiotic-associated diarrhoea, especially in Latin America, where its incidence increased considerably. Traditionally, it was treated with antibiotics such as metronidazole and vancomycin,
Stupnik , Juliana, Laube , Gerardo
core +1 more source

